28 completed. 28 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 28 | Completed 28 |
| Phase 2 | 4 | Completed 4 |
Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of Setmelanotide Setmelanotide - Obesity Associated With Defects in Leptin-melanocortin Pathway | Phase 3 | Completed | Rhythm Pharmaceuticals, Inc. | 28 | 2024-10-21 | 2026-07-15 |
| Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia Chronocort, Cortef, Placebo - Congenital Adrenal Hyperplasia | Phase 3 | Completed | Neurocrine UK Limited | 55 | 2022-05-24 | 2026-10-02 |
| Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia Chronocort - Congenital Adrenal Hyperplasia | Phase 3 | Completed | Immedica Pharma AB | 76 | 2022-04-01 | 2026-06-18 |
| A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Placebo Oral Capsule, Bardoxolone Methyl - Alport Syndrome | Phase 2 / Phase 3 | Completed | Biogen | 187 | 2017-03-02 | 2025-06-11 |
| Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy Exenatide, Placebo - Craniopharyngiomas, Hypothalamic Obesity | Phase 3 | Completed | University Hospital, Bordeaux | 42 | 2017-01-11 | 2026-05-22 |
| Isoamyl 2-Cyanoacrylate in the Urethro-cutaneous Fistula Repair Cyanoacrylate, Isobutyl, Classic surgical repair - Hypospadias | Phase 2 / Phase 3 | Completed | Ain Shams University | 40 | 2017-01-01 | 2021-05-07 |
| A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH Hydrocortisone - Congenital Adrenal Hyperplasia | Phase 3 | Completed | Neurocrine UK Limited | 91 | 2016-08-18 | 2026-10-02 |
| Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity Exenatide, placebo - Hypothalamic Obesity | Phase 3 | Completed | Seattle Children's Hospital | 42 | 2016-03-01 | 2022-05-05 |
| Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia Chronocort®, standard glucocorticoid therapy - Congenital Adrenal Hyperplasia | Phase 3 | Completed | Neurocrine UK Limited | 122 | 2016-02-22 | 2026-10-02 |
| Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair Bupivacaine, General anesthesia, Dilute epinephrine injection - Hypospadias | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 60 | 2014-09-01 | 2016-04-26 |
| A Clinical Study to Assess the Efficacy and Safety of DA-3002 DA-3002, Genotropin® - Turner's Syndrome | Phase 3 | Completed | Dong-A ST Co., Ltd. | 58 | 2013-02-01 | 2018-07-26 |
| Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome Ramipril, placebo to ramipril - Renal Insufficiency, Chronic | Phase 3 | Completed | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 66 | 2012-03-01 | 2020-06-17 |
| Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications promestriene, Placebo, Urethroplasty - Hypospadias | Phase 3 | Completed | Hospices Civils de Lyon | 244 | 2011-05-26 | 2025-09-04 |
| Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome doxycycline, Sugar Pill - Polycystic Ovarian Syndrome (PCOS), Irregular Menstrual Cycles | Phase 3 | Completed | University of Rochester | 10 | 2010-11-01 | 2016-01-13 |
| Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) asenapine - Schizophrenia, Paranoid, Schizophrenia, Disorganized | Phase 3 | Completed | Organon and Co | 204 | 2010-09-28 | 2024-05-22 |
| Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) asenapine 2.5 mg, asenapine 5.0 mg, placebo - Schizophrenia, Paranoid, Schizophrenia, Disorganized | Phase 3 | Completed | Organon and Co | 306 | 2010-09-28 | 2024-05-21 |
| Androgen for Leydig Cell Proliferation Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism | Phase 2 / Phase 3 | Completed | University of Roma La Sapienza | 56 | 2009-06-01 | 2018-09-25 |
| An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG ZOMACTON - Turner's Syndrome | Phase 3 | Completed | Ferring Pharmaceuticals | 27 | 2005-10-01 | 2011-05-20 |
| Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Somatropin (rDNA origin) - Turner Syndrome, Renal Insufficiency, Chronic | Phase 3 | Completed | Ipsen | 251 | 2004-06-01 | 2019-12-09 |
| Estrogen Treatment (Oral vs. Patches) in Turner Syndrome 17 beta estradiol - Turner Syndrome, Hypogonadism | Phase 3 | Completed | Nemours Children's Clinic | 16 | 2001-01-01 | 2017-11-30 |
Showing 20 of 28. Sign in to see all of them.
Turner Syndrome (10) · Adrenal Hyperplasia, Congenital (5) · Dwarfism (3) · Genetic Diseases, Inborn (3) · Hypospadias (3) · Sexual Infantilism (3) · Disorders of Sex Development (2) · Hyperandrogenism (2) · Hypogonadism (2) · Infertility (2) · Nephritis, Hereditary (2) · Obesity (2) · Polycystic Ovary Syndrome (2) · Renal Insufficiency, Chronic (2) · Schizophrenia (2)
Congenital Abnormalities (28) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (28) · Female Urogenital Diseases (28) · Female Urogenital Diseases and Pregnancy Complications (28) · Male Urogenital Diseases (28) · Urogenital Diseases (28) · Endocrine System Diseases (23) · Gonadal Disorders (23) · Disorders of Sex Development (21) · Genetic Diseases, Inborn (13) · Gonadal Dysgenesis (13) · Chromosome Disorders (11) · Sex Chromosome Disorders (11) · Sex Chromosome Disorders of Sex Development (11)
Human Growth Hormone (6) · Hydrocortisone (4) · Estradiol (2) · Exenatide (2) · Growth Hormone (2) · asenapine (2) · Androgens (1) · Anesthesia, General (1) · Atropine (1) · Bucrylate (1) · Bupivacaine (1) · Castor Oil (1) · Clomiphene (1) · Dexamethasone (1) · Doxycycline (1)
Neurocrine UK Limited (3) · Novo Nordisk A/S (3) · Eli Lilly and Company (2) · Organon and Co (2) · 59th Medical Wing (1) · Ain Shams University (1) · Biogen (1) · Dong-A ST Co., Ltd. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Ferring Pharmaceuticals (1) · Hospices Civils de Lyon (1) · Immedica Pharma AB (1) · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH (1) · Ipsen (1) · Isfahan University of Medical Sciences (1)
United States (13) · France (7) · Germany (3) · Japan (3) · Spain (3) · United Kingdom (3) · Czechia (2) · Italy (2) · Australia (1) · Belgium (1) · Canada (1) · Denmark (1) · Egypt (1) · Finland (1) · Greece (1)
Andrea Isidori, MD, PhD (1) · Andrea Lenzi, MD (1) · Blandine Gatta-Cherifi, Pr (1) · Byung Kyu Suh, M.D., Ph.D. (1) · Chang Jong Kim, M.D., Ph.D. (1) · Cheol Woo Ko, M.D., Ph.D. (1) · Choong Ho Shin, M.D., Ph.D. (1) · Christian Roth, MD (1) · D Merke (1) · David Meeker, MD (1)
PMID 26091193, PMID 33159213, PMID 33527139, PMID 15784709, PMID 16757526, PMID 20733274, PMID 21619701, PMID 24529291, PMID 31532522, PMID 32299679, PMID 32386308, PMID 33040356, PMID 33789284, PMID 34893062, PMID 36411058, PMID 38450721, PMID 39672600
2009 (2), 2004 (1)